Related Experiment Video

Updated: Mar 29, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

726

Lin28a protects against diabetic cardiomyopathy via the PKA/ROCK2 pathway

Shuhong Sun1, Mingming Zhang2, Jie Lin2

  • 1Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China; Department of Cardiology, Shaanxi Provincial Crops Hospital, Chinese People's Armed Police Forces, Xi' an, 710054, China.

Biochemical and Biophysical Research Communications
|December 3, 2015
PubMed
Abstract

Insights

Lin28a protects against diabetic cardiomyopathy by improving cardiac function and reducing cell death. This protein may be a promising therapeutic target for treating diabetes-related heart conditions.

Area of Science:

  • Cardiovascular Research
  • Metabolic Diseases
  • Molecular Biology

Background:

  • Lin28a is known to improve glucose uptake and insulin sensitivity.
  • The specific role of Lin28a in experimental diabetic cardiomyopathy (DCM) remains unclear.
  • Diabetes-induced myocardial dysfunction is a significant health concern.

Purpose of the Study:

  • To investigate the protective role of Lin28a in diabetes-induced myocardial dysfunction.
  • To elucidate the underlying mechanisms of Lin28a's action in DCM.
  • To explore Lin28a as a potential therapeutic target for DCM.

Main Methods:

  • Diabetes was induced using Streptozocin (STZ) in mice.
  • Mice were treated with lentivirus carrying Lin28a siRNA or cDNA.
  • Cardiac function, autophagy, apoptosis, and mitochondrial morphology were assessed.

Main Results:

  • Lin28a levels were reduced in diabetic mouse hearts.
  • Lin28a overexpression improved cardiac function, enhanced autophagy, and reduced apoptosis and mitochondrial damage.
  • Lin28a knockdown worsened diabetic cardiac injury.
  • PKA inhibition abolished the protective effects of Lin28a.
  • Lin28a modulated RhoA and ROCK2 expression.

Conclusions:

  • Lin28a confers protection against diabetic cardiomyopathy via a PKA/ROCK2-dependent pathway.
  • Lin28a demonstrates potential as a therapeutic target for DCM patients.
Keywords:
ApoptosisAutophagyDiabetic cardiomyopathy DCMLin28a

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.7K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K